FSRT with Avastin for multiple brain tumors from lung cancer
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests giving focused radiation (FSRT) along with Avastin (bevacizumab) to people with multiple brain metastases from lung adenocarcinoma. It aims to see if combining these treatments is safe and effective for tumors that are too large or numerous for standard one-time radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with lung adenocarcinoma (a type of lung cancer).
- An MRI of your brain shows between 1 and 20 metastases (tumors that spread from the lung), with some tumors large enough that doctors think regular one-session radiation isn't suitable.
- Your cancer outside the brain is stable (not getting worse) at the time you join.
- You are in generally good physical condition (able to care for yourself and do daily activities).
- Your blood counts, liver, and kidney function are within a healthy range based on tests done within 2 weeks before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver radiation to brain metastases from non-small cell lung cancer, using MRI scans to guide the treatment and reduce the area exposed. The goal is to see if this approach is safe and effective while possibly lowering side effects.
This trial tests combining a drug called bevacizumab with a focused radiation treatment for people with lung cancer that has spread to the brain. It compares this to the standard radiation approach, and aims to see which better preserves memory and controls tumors.
This Phase 1 study tests a form of focused radiation given in stages to shrink larger brain metastases. It may help people whose tumors are in the brain but not suited to whole-brain radiation alone, while also checking safety and how well the treatment can be delivered.
This trial tests a combination of radiation to the brain plus chemotherapy and immunotherapy (anti-PD-1/PD-L1) for people with newly diagnosed non-small cell lung cancer that has spread to the brain. It is for those whose tumors do not have common driver mutations and whose brain metastases are causing symptoms.
This trial tests whether combining brain radiation with chemotherapy and immunotherapy can help people with advanced lung cancer that has spread to the brain but has not yet been treated. It is for those whose tumors do not have certain gene mutations (EGFR, ALK, ROS1).
This study tests a targeted radiation treatment for brain tumors that have spread from lung cancer and may not have responded to other treatments. The goal is to see if this precise radiation approach can shrink these tumors and improve survival with fewer side effects.
Hear when a new Multiple Brain Metastases in Lung Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.